Patrick Wood

Stock Analyst at Morgan Stanley

(0)
# 3242
Out of 5,240 analysts
77
Total ratings
48.00%
Success rate
3.02%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Cooper Companies
Maintains: Equal-Weight
104 102
89.03 14.57% 5 Dec 6, 2024
Tandem Diabetes Care
Upgrades: Overweight
45 45
35.79 25.73% 3 Dec 2, 2024
Glaukos
Downgrades: Underweight
120
148.27 -19.07% 3 Dec 2, 2024
Bausch & Lomb
Downgrades: Equal-Weight
19
17.23 10.27% 6 Dec 2, 2024
PROCEPT BioRobotics
Initiates Coverage On: Overweight
105
81.58 28.71% 1 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
60 73
70.23 3.94% 3 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
234 317
267.3 18.59% 5 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 100
95.55 4.66% 4 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Equal-Weight
70
71.02 -1.44% 7 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
120 75
79.23 -5.34% 6 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 10
12.84 -22.12% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
104 145
62.57 131.74% 1 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
65 85
82.68 2.81% 3 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 37
21.62 71.14% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
39 30
30.61 -1.99% 3 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
285 335
n/a n/a 6 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
74 86
84.09 2.27% 5 Feb 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
225 215
207.46 3.63% 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
310 280
235.82 18.73% 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
n/a
n/a n/a 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
36
30.09 19.64% 1 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Dec 11, 2017